Restivo, Leonardo https://orcid.org/0000-0002-3709-5504
Gerlach, Björn https://orcid.org/0000-0002-4900-6302
Tsoory, Michael https://orcid.org/0000-0003-0441-8757
Bikovski, Lior
Badurek, Sylvia https://orcid.org/0000-0003-0808-2920
Pitzer, Claudia https://orcid.org/0000-0002-7663-1031
Kos-Braun, Isabelle C https://orcid.org/0000-0002-2380-5720
Mausset-Bonnefont, Anne-Laure MJ https://orcid.org/0000-0003-4119-1475
Ward, Jonathan
Schunn, Michael
Noldus, Lucas PJJ https://orcid.org/0000-0003-3966-5598
Bespalov, Anton
Voikar, Vootele https://orcid.org/0000-0003-4201-8666
Funding for this research was provided by:
Biocenter Finland
Jane and Aatos Erkko Foundation
Bundesministerium für Bildung und Forschung (01PW18001)
Austrian Federal Ministry of Education, science & Research
Carolito Stiftung
Innovative Medicines Initiatives 2 joint Undertaking (777364)
European Union Horizon 2020 Research and Innovation program
European Federation of Pharmaceutical Industries and Associations
Faculty of Biology & Medicine, University of Lausanne
Article History
Received: 17 August 2021
Revised: 24 September 2021
Accepted: 18 October 2021
First Online: 4 November 2021
Conflict of interest
: BG and AB are employees and shareholders at PAASP GmbH.